Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
September 06, 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical CareSeptember 06, 2024 Eversheds Sutherland has advised Edwards Lifesciences on the US$4.2bn sale of its Critical Care product group to Becton, Dickinson and Company (BD). Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The Critical Care product group is an industry leader in advanced patient monitoring with advanced AI algorithms serving millions of patients globally. Key contacts
Lee Harris Partner United Kingdom Antony Walsh Partner United Kingdom Barri Mendelsohn Partner United Kingdom Rachel Cooper Partner United Kingdom Edward M. Tompkin-Haag Partner United Kingdom Kelly Holmes Partner United Kingdom Philip Crosbie Partner United Kingdom Christopher Murray Partner United Kingdom Latest Insights
Latest Events
legal updates November 13, 2026 COP31: Leaders’ Summit | Resilient Cities and Built Environment  legal updates November 12, 2026 COP31: Leaders’ Summit | Zero Waste - The business case for zero waste legal updates November 11, 2026 COP31: Energy and Transport – Electrification takes center stage in Antalya legal updates November 11, 2026 Algorithmic Management of Workforces: Is your business a “platform” without... hybrid Europe Action Week 2026 Europe Action Week returns this November with a dynamic mix of events designed to help you navigate what’s next. virtual Belgian employment law training November 17, 2026 2.00pm - 5.00pm (GMT) Virtual in-person Industrial relations masterclass November 18, 2026 9.30am - 4.30pm (GMT) London, United Kingdom virtual Immigration UK Business – sponsor licencing course November 24, 2026 9.30am - 11.30am (GMT) Virtual |